A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

NCT01760343 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema Types I and II

Interventions

BIOLOGICAL: Berinert
BIOLOGICAL: CSL830

Sponsor

CSL Behring